Platinum transporters and drug resistance

作者: Min-Koo Choi , Dae-Duk Kim

DOI: 10.1007/BF02969293

关键词:

摘要: Cisplatin, a platinum coordinated complex, is widely used antineoplastic agent for the treatment of metastatic tumors testis, ovarian tumors, lung cancer, advanced bladder cancer and many other solid tumors. The cytotoxic action drug often thought to be associated with its ability bind DNA form cisplatin-DNA adducts. development resistance cisplatin during common constitutes major obstacle cure sensitive Although understand clinically relevant mechanisms resistance, studies have been aimed at clarifying biochemical/molecular alterations cisplatin-resistance cells, these did not conclusively identify basis cellular cisplatin. In this review, was discussed in terms transporters, such as copper transporters (CTRs), organic cation (OCTs) multi-drug related (MDRs). These seem contributed through reduction accumulation cell. Better understanding mechanism will provide useful informations overcoming resistance.

参考文章(77)
Kazumasa Ikeda, Kyoko Miura, Seiichiro Himeno, Nobumasa Imura, Akira Naganuma, Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum. Molecular and Cellular Biochemistry. ,vol. 219, pp. 51- 56 ,(2001) , 10.1023/A:1011083429704
Zahid H. Siddik, Biochemical and molecular mechanisms of cisplatin resistance. Cancer treatment and research. ,vol. 112, pp. 263- 284 ,(2002) , 10.1007/978-1-4615-1173-1_13
Raymond B. Weiss, Michaele C. Christian, New cisplatin analogues in development. A review. Drugs. ,vol. 46, pp. 360- 377 ,(1993) , 10.2165/00003495-199346030-00003
Valeria Cizewski Culotta, Su-Ju Lin, Paul Schmidt, Leo W. J. Klomp, Ruby Leah B. Casareno, Jonathan Gitlin, Intracellular Pathways of Copper Trafficking in Yeast and Humans Advances in Experimental Medicine and Biology. ,vol. 448, pp. 247- 254 ,(1999) , 10.1007/978-1-4615-4859-1_22
Peter J. O'Dwyer, Andrew K. Godwin, Robert F. Ozols, Kang-Shen Yao, Thomas C. Hamilton, Steven W. Johnson, Evidence for Altered Regulation of γ-Glutamylcysteine Synthetase Gene Expression among Cisplatin-sensitive and Cisplatin-resistant Human Ovarian Cancer Cell Lines Cancer Research. ,vol. 55, pp. 4367- 4374 ,(1995)
Thomas Schöndorf, Rainer Neumann, Carolin Benz, Martina Becker, Marion Riffelmann, Uwe-Jochen Göhring, Judith Sartorius, Carl-Heinz Wirsing von König, Martina Breidenbach, Markus M. Valter, Markus Hoopmann, Federica Di Nicolantonio, Christian M. Kurbacher, Cisplatin, doxorubicin and paclitaxel induce mdr1 gene transcription in ovarian cancer cell lines. Recent results in cancer research. ,vol. 161, pp. 111- 116 ,(2003) , 10.1007/978-3-642-19022-3_10
Roohangiz Safaei, Goli Samimi, Myriam Rochdi, Alison Holzer, Akira Kondo, Misako Mishima, Stephen B Howell, Yien-Ming Kuo, Kuniyuki Katano, Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Research. ,vol. 62, pp. 6559- 6565 ,(2002)